Bronchiectasis
Bronchiectasis is characterized by irreversible anatomical abnormalities of local bronchi. It is caused by chronic suppurative inflammation and fibrosis of the bronchi and surrounding lung tissues, which destroy the muscle and elastic tissue of the bronchial wall, leading to bronchial deformation and persistent dilation. Typical clinical symptoms include chronic cough, coughing up large amounts of purulent sputum, and repeated hemoptysis. The main pathogenic factors are bronchial infection, obstruction, and traction, and some are congenital genetic factors. Most patients have a history of childhood measles, whooping cough, or bronchopneumonia. With the improvement of people's lives, vaccination against measles and whooping cough, and the use of antibiotics, this disease has been significantly reduced.
Related Drugs
Cefuroxime Sodium
Indication: This product can be used to treat the following infections caused by the above-mentioned sensitive bacteria: 1. Respiratory system infections: tonsillitis, peritonsillar abscess, bronchitis, bronchiolitis, bronchiectasis (when infected), secondary infections of chronic respiratory diseases, pneumonia, pulmonary suppuration; 2. Urinary system infections: pyelonephritis, cystitis; 3. Abdominal infections: cholecystitis, cholangitis, peritonitis; 4. Pelvic infections: pelvic peritonitis, adnexitis, intrauterine infection, pelvic dead cavity inflammation, parametrial tissue inflammation; 5. Sepsis.
Cefuroxime Sodium
Indication: This product can be used to treat the following infections caused by the above-mentioned sensitive bacteria: 1. Respiratory system infections: tonsillitis, peritonsillar abscess, bronchitis, bronchiolitis, bronchiectasis (when infected), secondary infections of chronic respiratory diseases, pneumonia, pulmonary suppuration; 2. Urinary system infections: pyelonephritis, cystitis; 3. Abdominal infections: cholecystitis, cholangitis, peritonitis; 4. Pelvic infections: pelvic peritonitis, adnexitis, intrauterine infection, pelvic dead cavity inflammation, parametrial tissue inflammation; 5. Sepsis.
Manufacturer:
Hainan New Way Pharmaceufical Co., Ltd.
Cefuroxime Sodium
Indication: This product can be used to treat the following infections caused by the above-mentioned sensitive bacteria: 1. Respiratory system infections: tonsillitis, peritonsillar abscess, bronchitis, bronchiolitis, bronchiectasis (when infected), secondary infections of chronic respiratory diseases, pneumonia, pulmonary suppuration; 2. Urinary system infections: pyelonephritis, cystitis; 3. Abdominal infections: cholecystitis, cholangitis, peritonitis; 4. Pelvic infections: pelvic peritonitis, adnexitis, intrauterine infection, pelvic dead cavity inflammation, parametrial tissue inflammation; 5. Sepsis.
Cefuroxime Sodium
Indication: This product can be used to treat the following infections caused by the above-mentioned sensitive bacteria: 1. Respiratory system infections: tonsillitis, peritonsillar abscess, bronchitis, bronchiolitis, bronchiectasis (when infected), secondary infections of chronic respiratory diseases, pneumonia, pulmonary suppuration; 2. Urinary system infections: pyelonephritis, cystitis; 3. Abdominal infections: cholecystitis, cholangitis, peritonitis; 4. Pelvic infections: pelvic peritonitis, adnexitis, intrauterine infection, pelvic dead cavity inflammation, parametrial tissue inflammation; 5. Sepsis.
Manufacturer:
Henan Kangda Pharmaceutical Co., Ltd.
Cefuroxime Sodium
Indication: This product can be used to treat the following infections caused by the above-mentioned sensitive bacteria: 1. Respiratory system infections: tonsillitis, peritonsillar abscess, bronchitis, bronchiolitis, bronchiectasis (when infected), secondary infections of chronic respiratory diseases, pneumonia, pulmonary suppuration; 2. Urinary system infections: pyelonephritis, cystitis; 3. Abdominal infections: cholecystitis, cholangitis, peritonitis; 4. Pelvic infections: pelvic peritonitis, adnexitis, intrauterine infection, pelvic dead cavity inflammation, parametrial tissue inflammation; 5. Sepsis.
Tiotropium Bromide Powder for Inhalation
Indication: This product is a bronchodilator, suitable for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, the maintenance treatment of dyspnea and the prevention of acute attacks.
Bambuterol Hydrochloride Tablets
Indication: Used for bronchial asthma, chronic asthmatic bronchitis, obstructive pulmonary emphysema and other lung diseases accompanied by bronchospasm.
Manufacturer:
AstraZeneca Pharmaceutical Co., Ltd.